Opportunities and Challenges of Biosimilars in EU, US and Russia
Opportunities and Challenges of Biosimilars in EU, US and Russia
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |